Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 394,581
  • Shares Outstanding, K 32,610
  • Annual Sales, $ 90 K
  • Annual Income, $ -57,280 K
  • 36-Month Beta 3.02
  • Price/Sales 4,618.20
  • Price/Cash Flow 0.00
  • Price/Book 4.01

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.11 +9.81%
on 11/03/17
13.52 -9.76%
on 11/13/17
-0.23 (-1.85%)
since 10/20/17
3-Month
11.11 +9.81%
on 11/03/17
14.70 -17.01%
on 09/08/17
-0.64 (-4.98%)
since 08/21/17
52-Week
8.61 +41.70%
on 12/01/16
28.50 -57.19%
on 06/27/17
+0.91 (+8.06%)
since 11/21/16

Most Recent Stories

More News
Therapeutic Advancements in Breakthrough Therapies for Treating Chronic Pain Take aim at Reducing Opioid use

A new study conducted by researchers at the University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the...

TRVN : 1.77 (+1.72%)
CARA : 12.08 (-0.17%)
COLL : 18.05 (+2.56%)
VRTHF : 0.4600 (+4.55%)
VRT.CN : 0.580 (+3.57%)
PRGO : 87.13 (+2.27%)
Innovation Drives Value for Leading Cannabis Biotechs

The medicinal cannabis market is expected to reach almost US$56 billion by 2025, according to a report by Grand View Research (http://nnw.fm/rXx0Z), driven in part by demand for therapeutic applications...

IMLFF : 0.6090 (+4.50%)
CARA : 12.08 (-0.17%)
GWPH : 124.62 (+8.58%)
INSY : 5.16 (-0.77%)
ZYNE : 13.66 (+1.64%)
IN.CN : 0.750 (+7.14%)
Research for Advanced Treatments Move in the Right Direction to Combat Opioid Epidemic

PALM BEACH, Florida, November 10, 2017 /PRNewswire/ --

TRPX : 5.26 (-2.23%)
TRVN : 1.77 (+1.72%)
CARA : 12.08 (-0.17%)
COLL : 18.05 (+2.56%)
PRGO : 87.13 (+2.27%)
Research for Advanced Treatments Move in the Right Direction to Combat Opioid Epidemic

According to Additions.com, Opioid addiction rates have skyrocketed over the past two decades, costing millions in health insurance costs and lost productivity in the workforce. According to Fortune magazine,...

TRPX : 5.26 (-2.23%)
TRVN : 1.77 (+1.72%)
CARA : 12.08 (-0.17%)
COLL : 18.05 (+2.56%)
PRGO : 87.13 (+2.27%)
Cara Therapeutics to Present at November Investor Conferences

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral...

CARA : 12.08 (-0.17%)
Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs

PALM BEACH, Florida, November 7, 2017 /PRNewswire/ --

CARA : 12.08 (-0.17%)
CTXR : 5.04 (+5.66%)
ONCS : 2.08 (-0.95%)
TXMD : 5.99 (+1.53%)
VBLT : 6.95 (+0.72%)
Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs

Commitment to bring new drug developments to the market through highly regarded and respected clinical research and studies are of a continued result of ongoing collaborations with academic and medical...

CARA : 12.08 (-0.17%)
CTXR : 5.04 (+5.66%)
ONCS : 2.08 (-0.95%)
VBLT : 6.95 (+0.72%)
TXMD : 5.99 (+1.53%)
Technical Insights on Biotech Stocks -- Cara Therapeutics, Catabasis Pharma, Cerus, and Genocea Biosciences

If you want a Stock Review on CARA, CATB, CERS, or GNCA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Friday, benchmark US indices were in bullish...

CARA : 12.08 (-0.17%)
CATB : 1.77 (+3.51%)
GNCA : 1.16 (+3.57%)
CERS : 3.76 (+0.27%)
Cara Therapeutics Reports Third Quarter 2017 Financial Results

Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral...

CARA : 12.08 (-0.17%)
Cara Therapeutics Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 2, 2017 / Cara Therapeutics Inc (NASDAQ: CARA) will be discussing their earnings results in their Q3 Earnings Call to be held on November 2, 2017 at 4:30 PM Eastern...

CARA : 12.08 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

2nd Resistance Point 12.39
1st Resistance Point 12.25
Last Price 12.08
1st Support Level 12.00
2nd Support Level 11.89

See More

52-Week High 28.50
Fibonacci 61.8% 20.90
Fibonacci 50% 18.56
Fibonacci 38.2% 16.21
Last Price 12.08
52-Week Low 8.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart